Actelion: No Rest for the Weary
EP Vantage
•
Mon, Sep 27, 2010
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Biotech Clinical Trials Update: Roche, CytRx and ActelionRoger Newman • Mon, Aug 8, 2011 -
-
-
-
-
Amgen: FDA OK for Osteoporosis Therapy Is Welcome NewsEP Vantage • Sun, Nov 21, 2010
-
-
Biogen Pays Pretty Price to Expand ALS PipelineEP Vantage • Thu, Aug 19, 2010
-
A Delay in Protalix's Uplyso FDA Review Is Not a DisasterEP Vantage • Wed, Jul 14, 2010
-
-
Sanofi Pulls the Plug on Two Drugs: Biotech's Latest MishapsThe Burrill Report • Thu, Dec 24, 2009
-
European Shares Advance, U.S. Futures StallThe LFB • Mon, Dec 21, 2009 -
Making and Breaking Biotech DealsThe Burrill Report • Mon, Dec 14, 2009
-
-
Connor Browne: Asset Allocation Is Key in Current EnvironmentBenjamin Shepherd • Wed, Nov 18, 2009 -
-
There are no News articles on ALIOF.PK.
ALIOF.PK vs. ETF Alternatives
Company Description
Currently, there's no company description for ALIOF.PK.